| Andrea N Davis, MPT | |
|
1004 Progress Dr, Suite 100, Lansing, KS 66043-6326 | |
| (913) 351-3838 | |
| (913) 351-3939 |
| Full Name | Andrea N Davis |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 20 Years |
| Location | 1004 Progress Dr, Lansing, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689765588 | NPI | - | NPPES |
| MA4370056 | Other | MO | MEDICARE PTAN |
| 1689765588 | Other | KS | BCBS KS |
| KA2868024 | Other | KS | MEDICARE PTAN |
| 45792042 | Other | BCBS KC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2010017119 (Missouri) | Secondary |
| 225100000X | Physical Therapist | 11-04531 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Serc Rehabilitation Partners Llc | 9830344563 | 195 |
| Serc Rehabilitation Partners Llc | 9830344563 | 195 |
News Archive
Michigan State University researchers, who were the first to suggest that high blood pressure could be caused by belly fat hormones "talking" with blood vessels in the abdomen, have received a nearly $7 million National Institutes of Health grant to further their work.
As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.
The global age-standardized lung cancer mortality rate among women is projected to increase by 43 percent from 2015 to 2030, according to an analysis of data from 52 countries. The global age-standardized breast cancer mortality rate is projected to decrease by 9 percent in the same time frame.
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis, or PDP. The study did not meet its primary endpoint of antipsychotic efficacy as measured using the Scale for the Assessment of Positive Symptoms, or SAPS.
A letter from the office of Rep. Gabrielle Giffords, D-Ariz., urges HHS Secretary Kathleen Sebelius to include such care in the health law's essential benefits package, despite budget pressures looming in Congress.
› Verified 8 days ago
| Provider Name | Serc Rehabilitation Partners Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1760745244 PECOS PAC ID: 9830344563 Enrollment ID: O20130304000500 |
News Archive
Michigan State University researchers, who were the first to suggest that high blood pressure could be caused by belly fat hormones "talking" with blood vessels in the abdomen, have received a nearly $7 million National Institutes of Health grant to further their work.
As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.
The global age-standardized lung cancer mortality rate among women is projected to increase by 43 percent from 2015 to 2030, according to an analysis of data from 52 countries. The global age-standardized breast cancer mortality rate is projected to decrease by 9 percent in the same time frame.
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis, or PDP. The study did not meet its primary endpoint of antipsychotic efficacy as measured using the Scale for the Assessment of Positive Symptoms, or SAPS.
A letter from the office of Rep. Gabrielle Giffords, D-Ariz., urges HHS Secretary Kathleen Sebelius to include such care in the health law's essential benefits package, despite budget pressures looming in Congress.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea N Davis, MPT 17134 Bel Ray Pl, Belton, MO 64012-5331 Ph: (816) 226-4011 | Andrea N Davis, MPT 1004 Progress Dr, Suite 100, Lansing, KS 66043-6326 Ph: (913) 351-3838 |
News Archive
Michigan State University researchers, who were the first to suggest that high blood pressure could be caused by belly fat hormones "talking" with blood vessels in the abdomen, have received a nearly $7 million National Institutes of Health grant to further their work.
As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.
The global age-standardized lung cancer mortality rate among women is projected to increase by 43 percent from 2015 to 2030, according to an analysis of data from 52 countries. The global age-standardized breast cancer mortality rate is projected to decrease by 9 percent in the same time frame.
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis, or PDP. The study did not meet its primary endpoint of antipsychotic efficacy as measured using the Scale for the Assessment of Positive Symptoms, or SAPS.
A letter from the office of Rep. Gabrielle Giffords, D-Ariz., urges HHS Secretary Kathleen Sebelius to include such care in the health law's essential benefits package, despite budget pressures looming in Congress.
› Verified 8 days ago
Katherine Marie Martin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 712 1st Ter, Ste 103, Lansing, KS 66043 Phone: 913-727-2022 Fax: 913-727-2033 | |
Mike A Mendiola, BS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1004 Progress Dr, Ste 100, Lansing, KS 66043 Phone: 913-351-3838 Fax: 913-351-3939 | |
Leif Erick Sanford, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 100 E Kansas St Ste C, Lansing, KS 66043 Phone: 913-758-0283 | |
Trisha M. Mcculloch, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 712 1st Ter, Ste 103, Lansing, KS 66043 Phone: 913-727-2022 Fax: 913-727-2033 | |
Erin Katie Idacavage, PT, MPT, GCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 1004 Progress Dr Ste 100, Lansing, KS 66043 Phone: 913-351-3838 Fax: 913-351-3939 | |
Linda A Stelter, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 N Plaza Dr, Lansing, KS 66043 Phone: 913-727-1284 | |
Jason S Langford, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1004 Progress Dr, Suite 100, Lansing, KS 66043 Phone: 913-351-3838 Fax: 913-351-3939 |